Jing Li

Gynecologic oncologist; MD, PhD; Associate professor; Department of Gynecologic Oncology, Sun Yat-sen Memorial Hospital, Guangzhou, China.

[Jing Li @RichardJing4]

@leitaomd Cannot agree with you anymore

[Jing Li @RichardJing4]

@leitaomd @zivanovicmd @MSKCancerCenter @TeamOvary_MSK @TeamEndo_MSK This story is very touching.

[Jing Li @RichardJing4]

@MatteoLoverro Great work!

[Jing Li @RichardJing4]

Cervical SC carcinoma, clinical stage IB2(FIGO IIIC2 p). Extensive para-aortic lymph node (Max 6cm) metastasis with swollen lymph nodes encircling the aorta and inferior vena cava. All removed.🤩😍😍😍

[Jing Li @RichardJing4]

@nephgirlsketch So amazing

[Jing Li @RichardJing4]

We should know patients with III-IVA disease benefit from the addition of Pemb. https://t.co/8dAOa3QH5S

[Jing Li @RichardJing4]

@Dra_AnaConde @agz_eriksson @MDAnderson_ES team work makes dreams work👍👍👍👍👍👍

[Jing Li @RichardJing4]

Thrilled to shard that our work just went online in @NatureCommunications.👏👏 Hyperthermia+WEE1 inhibitors👉👉synthetic lethality. Promising implications for OC pts. Excited for upcoming clinical trials💪💪!! #gynecologic #HIPEC #OvarianCancer #WEE1 https://t.co/6w7h7vWqkH

[Jing Li @RichardJing4]

@Serge__MD Thanks😊😊😊😊😊😊

[Jing Li @RichardJing4]

@CNevrez Thx😊😊😊

[Jing Li @RichardJing4]

En-bloc posterior-pelvic exenteration, diaphragmatic stripping, and omentectomy. Hoping the patient benefits from an R0 resection.#gynecologic #oncology #OvarianCancer

[Jing Li @RichardJing4]

@BatistaTP 😊😊😊😊😊😊

[Jing Li @RichardJing4]

@BatistaTP IDS after 3 cycles of NACT. FIGO IVA with large amount of pleural effusion. Primary Fagotti score 10. thx.

[Jing Li @RichardJing4]

@AmelieFranken @MeeomHealthClub @ImmunityCP great job!

[Jing Li @RichardJing4]

Resection of hepatic hilar metastases is crucial in the surgical treatment of ovarian cancer. #gynecologiconcology #surgery #ovariancancer

[Jing Li @RichardJing4]

@BatistaTP @NEJM @glaucobaiocchi @IJGConline @pedroramirezMD The selection of patients is critical.

[NEJM @NEJM]

In the SHAPE randomized trial in patients with low-risk cervical cancer, simple hysterectomy was not inferior to radical hysterectomy with respect to 3-year pelvic recurrence & was associated with a lower risk of urologic complications. Full trial results: https://t.co/VyTlheyJlG

[Jing Li @RichardJing4]

Two cases we've recently worked on. Vulvar cancer: radical vulvectomy followed by vulvar reconstruction. Recurrent yolk sac tumor: Para-aortic M with AFP 1100. Para-aortic M dis+BEP chemo. Following 1st chemo, AFP neg. #SunYatsenMemorialHospital #GynecologicOncology

[Jing Li @RichardJing4]

Absolutely thrilled to be in Nagoya for #JSMO2024!

[Jing Li @RichardJing4]

@FarazKh65499316 👍

[Jing Li @RichardJing4]

≥8 OC surgeries + many more procedures for pts with EC & CC in high volume centers such as Sun Yat-sen Memorial Hospital. OR resource is limiting. Exploring the feasibility of HIPEC in General Wards is highly warranted. GARD-HIPEC is expected to enroll the 1st pts within 3 m!